SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 75.40+5.5%Nov 11 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (2505)6/8/2009 4:04:48 PM
From: Jibacoa  Read Replies (2) of 3722
 
KERX Is up 24.07% on volume of > 10,863,000 which is about 7x its ADV

The stock opened with a good UG without completely closing its previous UG of June 1. <g>

bigcharts.marketwatch.com

It announced today positive results on the PII of Zerenex (ferric citrate) for the treatment of hyperphosphatemia, in patients with end-stage renal disease on thrice weekly hemodialysis.

KERX was able to close on the black on its 1stQ(March) at $0.01 vs. loss of $0.49 in 2008. The EL for 2009 is around $0.35 vs. $0.89 in 2008 and for 2010 a further trim of the loss to $0.25/shr is expected.

YHOO has a 'target' of $3.80 as it seems that the stock wants to close some of its large DG of March 14 2008 <g>

bigcharts.marketwatch.com

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext